| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 11 May 2024 | 6 May 2024 |
| Dividend & Audited Results & Quarterly Results This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, May 11, 2024 inter-alia to consider the following: (i) to consider & approve annual financial statements (Standalone and consolidated) of the Company for financial year ended March 31, 2024 along with results of the fourth quarter; (ii) to consider & recommend Final Dividend if any for the financial year ended March 31, 2024 and/or consider and declare Interim Dividend if any, for the financial year ended March 31, 2025. Record date for determining the shareholders for the payment of the aforesaid Interim Dividend for FY 2024-25, if any declared by the Board of Directors of the Company shall be Saturday, May 18, 2024 (As Per BSE Announcement Dated on 04/05/2024) The Board of Directors of the Company, Recommended a Final Dividend @55% i.e. 1.1 /- per Equity share on the face value ?2 /- each for the financial year 2023-24, subject to the approval of the Shareholders at the ensuing 35th Annual General Meeting of the Company. The Company has informed the Exchange about the Outcome of the Board Meeting held on May 11, 2024; 1) Financial Results 2) Final Dividend 3) Interim Dividend Declared an Interim Dividend @ 200% i.e. Rs. 4/- per Equity Share on the Face Value of Rs. 2/- each for the Financial Year 2024-25 (As Per BSE Announcement Dated on 11.05.2024) Declared an Interim Dividend @ 200% i.e. 4/- per Equity Share on the face value of 2/- each for the financial year 2024-25. The Interim Dividend for Financial Year 2024-25 will be paid to those shareholders whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares determined with reference to the Record Date of May 18, 2024 (Saturday), already announced for the said purpose by the Company vide letter dated May 04, 2024. The aforesaid Interim Dividend will be paid to the Shareholders on or before June 05, 2024. (As Per BSE Announcement PDF Dated on 11.05.2024) | ||
| Board Meeting | 10 Feb 2024 | 3 Feb 2024 |
| Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31 2023. This is to inform you that the Board of Directors at its Meeting held on February 10, 2024 has inter alia, approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023 and acquisition of an additional stake of upto 5.89% of JC Biotech Private Limited Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023 (As Per BSE Announcement Dated on 10.02.2024) | ||
| Board Meeting | 7 Nov 2023 | 31 Oct 2023 |
| Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30 2023 With reference to the notice of Board Meeting dated October 31, 2023, we hereby inform that the Board of Directors at its Meeting held on November 07, 2023 (commenced at 11.25 a.m. and concluded at 11.55 a.m.) has inter alia, approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2023. In view of the aforesaid, we are enclosing Annexure I - Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2023 along with the Limited Review report issued by MSKA & Associates, Statutory Auditors of the Company as an Annexure. The aforesaid financial results and other documents are also being uploaded on the website of the Company i.e. www.advancedenzymes.com This is for your information and for public at large. with reference to the notice of Board Meeting dated October 31, 2023, we hereby inform that the Board of Directors at its Meeting held on November 07, 2023 has inter-alia approved the unaudited financial results (Standalone & Consolidated ) of the Company for the quarter and half year ended September 30, 2023. Outcome of Board Meeting held on November 07, 2023 (As Per BSE Announcement Dated on 07.11.2023) Extract of Un-audited Consolidated Financial Results for the quarter and half year ended September 30, 2023, published in The Free Press Journal and Navshakti on November 08, 2023 (As Per BSE Announcement Dated on 08.11.2023) | ||
| Board Meeting | 12 Aug 2023 | 4 Aug 2023 |
| Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2023. With reference to the notice of Board Meeting dated August 04, 2023, we hereby inform that the Board of Directors at its Meeting held on August 12, 2023 (commenced at 10.05 a.m. and concluded at 10.45 a.m.) has inter alia, approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2023. In view of the aforesaid, we are enclosing the following: - Annexure I - Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2023 along with the Limited Review report issued by MSKA & Associates, Statutory Auditors of the Company as an Annexure. The aforesaid financial results and other documents are also being uploaded on the website of the Company i.e. www.advancedenzymes.com Statement of Unaudited Standalone and Consolidated Financial Results of the Company for the Quater ended 30th June 2023 (As Per BSE Announcement Dated on 12/08/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
